Perbamed Invest GmbH, in enger Beziehung
buy disclosed on 25 Jun 2026 via BaFin managers' transactions
- Transaction value
- €22,281
- Copy Window
- Worth researching
- Data Confidence
- 92%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
Viromed Medical AG
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
5 disclosures
2 insiders
2 cluster signals
+2.9% avg. 30d outcome
Company facts
- Ticker / ISIN
- VME / DE000A40ZVN7
- Exchange
- GR
- Country
- DE
- Sector
- Not available
Disclosure history
Perbamed Invest GmbH, in enger Beziehung
buy disclosed on 25 Jun 2026 via BaFin managers' transactions
- Transaction value
- €3,670
- Copy Window
- Worth researching
- Data Confidence
- 92%
- Previous signal outcome
- 0.0%
Perbandt, Uwe, Vorstand
buy disclosed on 11 Jun 2026 via BaFin managers' transactions
- Transaction value
- €3,560
- Copy Window
- Be careful chasing
- Data Confidence
- 92%
- Previous signal outcome
- +4.3%
Perbandt, Uwe, Vorstand
buy disclosed on 8 Jun 2026 via BaFin managers' transactions
- Transaction value
- €3,911
- Copy Window
- Be careful chasing
- Data Confidence
- 92%
- Previous signal outcome
- +5.0%
Perbandt, Uwe, Vorstand
buy disclosed on 1 Jun 2026 via BaFin managers' transactions
- Transaction value
- €13,200
- Copy Window
- Still fresh
- Data Confidence
- 92%
- Previous signal outcome
- +5.2%